CTIC logo

CTI BioPharma (CTIC) Accounts Payable

Annual Accounts Payable

$2.01 M
-$1.88 M-48.39%

December 31, 2022

Summary

Performance

1-Year Change

-48.39%

3-Year Change

+100%

5-Year Change

-22.41%

15-Year Change

-22.41%

CTIC Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.06 M
CTIC annual accounts payable is currently -83.36% below its historical high of $12.06 million

3-Year Low

$2.01 M
CTIC annual accounts payable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Accounts Receivable

$15.39 M
CTIC annual accounts receivable is $15.39 million

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Quarterly Accounts Payable

$2.02 M
+$17.00 K+0.85%

March 31, 2023

Summary

Performance

3-Month Change

+0.85%

1-Year Change

-16.49%

3-Year Change

+123.76%

5-Year Change

-7.7%

CTIC Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$17.71 M
CTIC quarterly accounts payable is currently -88.57% below its historical high of $17.71 million

3-Year Low

$2.01 M
CTIC quarterly accounts payable is currently +0.85% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Accounts Receivable

$22.96 M
CTIC quarterly accounts receivable is $22.96 million

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Quarterly Total Assets

$112.27 M
CTIC quarterly total assets is $112.27 million

Quarterly Current Assets

$86.45 M
CTIC quarterly total current assets is $86.45 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CTIC Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.4%-16.5%
3 y3 years+100.0%+123.8%
5 y5 years-22.4%-7.7%

CTIC Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.4%at low-48.0%-0.8%
5 y5-year-48.4%-100.0%-48.0%-100.0%
alltimeall time-83.4%-100.0%-88.6%-100.0%

CTI BioPharma Accounts Payable History

DateAnnualQuarterly
Mar 2023
-
$2.02 M(+0.8%)
Dec 2022
$2.01 M(-48.4%)
$2.01 M(-17.8%)
Sep 2022
-
$2.44 M(-21.1%)
Jun 2022
-
$3.10 M(+27.7%)
Mar 2022
-
$2.42 M(-37.7%)
Dec 2021
$3.89 M(+137.7%)
$3.89 M(+118.1%)
Sep 2021
-
$1.78 M(+37.8%)
Jun 2021
-
$1.29 M(+10.6%)
Mar 2021
-
$1.17 M(-28.5%)
Dec 2020
$1.64 M(>+9900.0%)
$1.64 M(+757.1%)
Sep 2020
-
$191.00 K(-71.0%)
Jun 2020
-
$658.00 K(-27.3%)
Mar 2020
-
$905.00 K(>+9900.0%)
Dec 2019
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2019
-
$2.96 M(+170.8%)
Jun 2019
-
$1.09 M(-1.9%)
Mar 2019
-
$1.12 M(-75.2%)
Dec 2018
$4.50 M(+73.8%)
$4.50 M(+116.5%)
Sep 2018
-
$2.08 M(-44.1%)
Jun 2018
-
$3.71 M(+69.3%)
Mar 2018
-
$2.19 M(-15.2%)
Dec 2017
$2.59 M(-64.2%)
$2.59 M(+28.1%)
Sep 2017
-
$2.02 M(-49.7%)
Jun 2017
-
$4.01 M(-66.2%)
Mar 2017
-
$11.88 M(+64.4%)
Dec 2016
$7.23 M(-31.7%)
$7.23 M(-47.1%)
Sep 2016
-
$13.66 M(-2.6%)
Jun 2016
-
$14.03 M(-20.8%)
Mar 2016
-
$17.71 M(+67.3%)
Dec 2015
$10.58 M(+66.5%)
$10.58 M(-20.9%)
Sep 2015
-
$13.38 M(+19.7%)
Jun 2015
-
$11.18 M(+8.8%)
Mar 2015
-
$10.28 M(+61.7%)
Dec 2014
$6.36 M(+25.8%)
$6.36 M(+0.9%)
Sep 2014
-
$6.30 M(-2.3%)
Jun 2014
-
$6.44 M(+40.0%)
Mar 2014
-
$4.60 M(-8.8%)
Dec 2013
$5.05 M(-58.1%)
$5.05 M(-51.3%)
Sep 2013
-
$10.36 M(-8.6%)
Jun 2013
-
$11.34 M(+4.7%)
Mar 2013
-
$10.84 M(-10.2%)
Dec 2012
$12.06 M(+109.8%)
$12.06 M(+1.1%)
Sep 2012
-
$11.94 M(-11.7%)
Jun 2012
-
$13.52 M(+146.3%)
Mar 2012
-
$5.49 M(-4.5%)
Dec 2011
$5.75 M(-4.8%)
$5.75 M(-12.4%)
Sep 2011
-
$6.56 M(-10.2%)
Jun 2011
-
$7.31 M(+33.9%)
Mar 2011
-
$5.46 M(-9.6%)
Dec 2010
$6.04 M(-17.3%)
$6.04 M(-7.2%)
Sep 2010
-
$6.51 M(+5.2%)
Jun 2010
-
$6.19 M(-13.4%)
Mar 2010
-
$7.14 M(-2.1%)
DateAnnualQuarterly
Dec 2009
$7.30 M(-21.8%)
$7.30 M(+51.9%)
Sep 2009
-
$4.80 M(-58.5%)
Jun 2009
-
$11.59 M(-28.7%)
Mar 2009
-
$16.25 M(+74.2%)
Dec 2008
$9.33 M(+41.4%)
$9.33 M(-16.3%)
Sep 2008
-
$11.14 M(-13.9%)
Jun 2008
-
$12.94 M(+71.2%)
Mar 2008
-
$7.56 M(+14.6%)
Dec 2007
$6.59 M(+932.1%)
$6.59 M(+407.7%)
Sep 2007
-
$1.30 M(+25.5%)
Jun 2007
-
$1.03 M(+6.4%)
Mar 2007
-
$973.00 K(+52.3%)
Dec 2006
$639.00 K(-81.0%)
$639.00 K(-89.5%)
Sep 2006
-
$6.09 M(+145.4%)
Jun 2006
-
$2.48 M(-10.9%)
Mar 2006
-
$2.78 M(-17.4%)
Dec 2005
$3.37 M(-53.9%)
$3.37 M(-2.5%)
Sep 2005
-
$3.46 M(-24.8%)
Jun 2005
-
$4.60 M(-22.6%)
Mar 2005
-
$5.94 M(-18.7%)
Dec 2004
$7.31 M(+81.3%)
$7.31 M(+92.6%)
Sep 2004
-
$3.79 M(-38.1%)
Jun 2004
-
$6.13 M(+32.8%)
Mar 2004
-
$4.62 M(+14.6%)
Dec 2003
$4.03 M(+64.9%)
$4.03 M(+279.2%)
Sep 2003
-
$1.06 M(+15.2%)
Jun 2003
-
$923.00 K(-5.2%)
Mar 2003
-
$974.00 K(-60.1%)
Dec 2002
$2.44 M(+102.7%)
$2.44 M(+150.7%)
Sep 2002
-
$975.00 K(-15.4%)
Jun 2002
-
$1.15 M(+93.5%)
Mar 2002
-
$596.00 K(-50.6%)
Dec 2001
$1.21 M(+8.4%)
$1.21 M(+102.0%)
Sep 2001
-
$596.90 K(+18.3%)
Jun 2001
-
$504.50 K(-56.9%)
Mar 2001
-
$1.17 M(+5.2%)
Dec 2000
$1.11 M(-7.2%)
$1.11 M(+199.6%)
Sep 2000
-
$371.50 K(-30.4%)
Jun 2000
-
$533.40 K(-35.9%)
Mar 2000
-
$832.10 K(-30.7%)
Dec 1999
$1.20 M(+9.1%)
$1.20 M(+300.0%)
Sep 1999
-
$300.00 K(-50.0%)
Jun 1999
-
$600.00 K(+500.0%)
Mar 1999
-
$100.00 K(-90.9%)
Dec 1998
$1.10 M(+450.0%)
$1.10 M(+120.0%)
Sep 1998
-
$500.00 K(-50.0%)
Jun 1998
-
$1.00 M(-41.2%)
Mar 1998
-
$1.70 M(+750.0%)
Dec 1997
$200.00 K(-71.4%)
$200.00 K(+100.0%)
Sep 1997
-
$100.00 K(-93.3%)
Jun 1997
-
$1.50 M(+114.3%)
Mar 1997
-
$700.00 K
Dec 1996
$700.00 K
-

FAQ

  • What is CTI BioPharma annual accounts payable?
  • What is the all time high annual accounts payable for CTI BioPharma?
  • What is CTI BioPharma annual accounts payable year-on-year change?
  • What is CTI BioPharma quarterly accounts payable?
  • What is the all time high quarterly accounts payable for CTI BioPharma?
  • What is CTI BioPharma quarterly accounts payable year-on-year change?

What is CTI BioPharma annual accounts payable?

The current annual accounts payable of CTIC is $2.01 M

What is the all time high annual accounts payable for CTI BioPharma?

CTI BioPharma all-time high annual accounts payable is $12.06 M

What is CTI BioPharma annual accounts payable year-on-year change?

Over the past year, CTIC annual accounts payable has changed by -$1.88 M (-48.39%)

What is CTI BioPharma quarterly accounts payable?

The current quarterly accounts payable of CTIC is $2.02 M

What is the all time high quarterly accounts payable for CTI BioPharma?

CTI BioPharma all-time high quarterly accounts payable is $17.71 M

What is CTI BioPharma quarterly accounts payable year-on-year change?

Over the past year, CTIC quarterly accounts payable has changed by -$400.00 K (-16.49%)